Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
The most effective method to Stay away from Normal Traps While Recruiting a Material Organization - 2Zelensky confidant dismissed from further posts amid bribery scandal
- 3Black Friday streaming deals 2025: Grab the Disney+ Hulu bundle for only $5 and save over 60%
- 4Vote in favor of Your #1 Home Exercise Gear: Execution and Comfort Matter
- 5Astronomers detect rare 'free floating' exoplanet 10,000 light-years from Earth
- What to expect from the planets in 2026 — key dates and sky events
- This Miraculous, Cliff-Perched Town In The South Of France Is A Sacred European Gem
- Material of Innovativeness: A Survey of \Releasing Your Imaginative Potential\ Online Workmanship Course
- Find the Standards of Viable Refereeing: Settling Debates with Strategy
- 4 Electric Vehicle Brands: Execution, Unwavering quality, and Development
- I watched more than 500 new movies this year. These are the 25 best ones.
- IDF bans Android phones for senior officers, iPhones now mandatory, Army Radio reports
- New trailer for 'Bridgerton' Season 4 teases Benedict's love story: Watch it here
- 'The Housemaid' movie with Sydney Sweeney and Amanda Seyfried premieres this month. What the stars have said about the psychological thriller.
